Literature DB >> 27546288

B-cell malignancies: All roads lead to NF-κB activation.

Richard Rosenquist1, Kostas Stamatopoulos2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27546288     DOI： 10.1016/j.semcancer.2016.08.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN： 1044-579X            Impact factor:   15.707


× No keyword cloud information.
  3 in total

1.  Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects.

Authors:  H Yesid Estupiñán; Thibault Bouderlique; Chenfei He; Anna Berglöf; Dhanu Gupta; Osama Saher; Miguel Ángel Daza Cruz; Lucia Peña-Perez; Liang Yu; Rula Zain; Mikael C I Karlsson; Robert Månsson; C I Edvard Smith
Journal:  Blood Adv       Date:  2020-06-09

2.  MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphoma.

Authors:  Renhong Huang; Xiaowei Zhang; Zhijun Min; Abdelbari Sophia Shadia; Shun'e Yang; Xiaojian Liu
Journal:  Exp Ther Med       Date:  2018-09-03       Impact factor: 2.447

3.  KCTD15 deregulation is associated with alterations of the NF-κB signaling in both pathological and physiological model systems.

Authors:  Giovanni Smaldone; Luigi Coppola; Katia Pane; Monica Franzese; Giuliana Beneduce; Rosanna Parasole; Giuseppe Menna; Luigi Vitagliano; Marco Salvatore; Peppino Mirabelli
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.